{"companyId":272617,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"ゼンタリス・ファーマシューティカルズ株式会社","headOfficeLocation":"サンディエゴ, カリフォルニア州, アメリカ合衆国","presidentName":"ジュリー・イーストランド","companySummary":null,"stockCode":"ZNTL","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["zentalis.com"],"businessContents":["WEE1およびその他の新規経路を標的としたがん治療薬の開発。","卵巣がんやその他の腫瘍タイプの臨床試験を実施。"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://www.zentalis.com/about/company","scoreAbout":500,"scoreBusiness":0,"scoreGroup":0,"scoreCustomer":0}]}